Advertisement
Australia markets close in 1 hour 50 minutes
  • ALL ORDS

    7,810.20
    -88.70 (-1.12%)
     
  • ASX 200

    7,560.40
    -81.70 (-1.07%)
     
  • AUD/USD

    0.6399
    -0.0026 (-0.41%)
     
  • OIL

    84.83
    +2.10 (+2.54%)
     
  • GOLD

    2,404.20
    +6.20 (+0.26%)
     
  • Bitcoin AUD

    97,441.99
    +745.96 (+0.77%)
     
  • CMC Crypto 200

    1,286.39
    +400.85 (+44.02%)
     
  • AUD/EUR

    0.6013
    -0.0018 (-0.29%)
     
  • AUD/NZD

    1.0875
    +0.0000 (+0.00%)
     
  • NZX 50

    11,751.60
    -84.44 (-0.71%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,184.02
    -201.85 (-1.23%)
     
  • NIKKEI 225

    37,200.64
    -879.06 (-2.31%)
     

Johnson & Johnson vs. Novavax: Which Vaccine Is Best Against New Strains?

Johnson & Johnson vs. Novavax: Which Vaccine Is Best Against New Strains?

Johnson & Johnson and Novavax are approaching the finish line in this race. A U.S. Food and Drug Administration (FDA) committee meets today, Feb. 26, to discuss a possible Emergency Use Authorization (EUA) for the Johnson & Johnson candidate. A trial report released this week shows Johnson & Johnson's investigational vaccine fulfilled (and exceeded) efficacy and safety requirements.